Alzheimer’s research is latest casualty in Trump administration war against ‘DEI’
Grant cancellations at leading research institutions appear to target study of impacts of racism on brain health A new round of scientific grant cancellations has hit brain health and Alzheimer’s disease research at two leading research institutions, Emory University and the University of Pittsburgh. The latest cancellations are the Trump administration ’s most recent effort to remove disfavored…
Recent grant cancellations at Emory University and the University of Pittsburgh appear to target Alzheimer's disease and brain health research, specifically studies examining the impact of racism on brain health. At least three grants totaling $15 million were canceled by the Trump administration, which aims to remove disfavored topics from the National Institutes of Health's $47 billion scientific portfolio.
These cancellations represent a new wave of "test cases" for the administration's legal strategy, as past cancellations were deemed unlawful and ordered reinstated by a federal judge. However, the Supreme Court ruled in favor of the administration, allowing the cancellation of $783 million in NIH funding. The canceled grants focused on measuring the effects of discrimination on long-term brain health, which researchers claim are scientifically valid concepts.
The NIH director stated that the projects no longer align with the NIH's priorities, questioning the measurability of the outcomes.
Written by urgent.news from Guardian Health's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
